Related Experiment Video

Updated: Jul 5, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?

Luke A J O'Neill1

  • 1School of Biochemistry and Immunology at Trinity College Dublin, Ireland. laoneill@tcd.ie

Nature Clinical Practice. Rheumatology
|May 1, 2008
PubMed

Insights

Toll-like receptors (TLRs) are promising therapeutic targets for inflammatory joint diseases like rheumatoid arthritis. Targeting specific TLRs and their signaling pathways may offer a more selective approach to treatment.

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • Toll-like receptors (TLRs) are key players in immune responses.
  • Dysregulated TLR signaling contributes to inflammatory joint diseases such as rheumatoid arthritis and systemic lupus erythematosus.

Purpose of the Study:

  • To explore the therapeutic potential of targeting Toll-like receptors (TLRs) and their signaling pathways for inflammatory joint diseases.
  • To evaluate TLRs as selective targets compared to broad signal inhibitors.

Main Methods:

  • Investigated TLR signaling pathways, including adaptor proteins (MyD88, Mal, TRIF, TRAM) and co-receptors (MD2, CD36).
  • Examined the effects of inhibiting specific TLRs (TLR4, TLR7, TLR9) and signaling components (Mal, MyD88, Unc93b).

Main Results:

  • TLR signaling induces pro-inflammatory cytokines like tumor necrosis factor and interferon alpha.
  • Inhibition of Mal or MyD88 effectively blocks inflammatory mediator production in synovial tissue.
  • Targeting TLR4, TLR7, and TLR9 shows promising results for treating inflammatory joint conditions.

Conclusions:

  • TLRs and their associated signaling pathways represent significant potential as novel therapeutic targets for inflammatory joint diseases.
  • Targeting specific TLRs offers a more selective approach than inhibiting global signaling pathways.

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...